The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
HER2 Antibodies-Global Market Insights and Sales Trends 2024
Synopsis
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.
The global HER2 Antibodies market size is expected to reach US$ 12010 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of HER2 Antibodies in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and E-commerce,, are propelling HER2 Antibodies market. Trastuzumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lapatinib segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for HER2 Antibodies market, driven by demand from China, the second largest economy with some signs of stabilising, the HER2 Antibodies market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HER2 Antibodies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HER2 Antibodies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HER2 Antibodies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HER2 Antibodies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HER2 Antibodies covered in this report include Novartis, Pfizer, Roche, Abnova, InvivoGen, Celltrion, Biocon and Novus Biologicals, etc.
The global HER2 Antibodies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals
Global HER2 Antibodies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HER2 Antibodies market, Segment by Type:
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Global HER2 Antibodies market, by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HER2 Antibodies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.
The global HER2 Antibodies market size is expected to reach US$ 12010 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of HER2 Antibodies in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and E-commerce,, are propelling HER2 Antibodies market. Trastuzumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lapatinib segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for HER2 Antibodies market, driven by demand from China, the second largest economy with some signs of stabilising, the HER2 Antibodies market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HER2 Antibodies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HER2 Antibodies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HER2 Antibodies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HER2 Antibodies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HER2 Antibodies covered in this report include Novartis, Pfizer, Roche, Abnova, InvivoGen, Celltrion, Biocon and Novus Biologicals, etc.
The global HER2 Antibodies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals
Global HER2 Antibodies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HER2 Antibodies market, Segment by Type:
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Global HER2 Antibodies market, by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HER2 Antibodies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of HER2 Antibodies
1.1 HER2 Antibodies Market Overview
1.1.1 HER2 Antibodies Product Scope
1.1.2 HER2 Antibodies Market Status and Outlook
1.2 Global HER2 Antibodies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HER2 Antibodies Market Size by Region (2018-2029)
1.4 Global HER2 Antibodies Historic Market Size by Region (2018-2023)
1.5 Global HER2 Antibodies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HER2 Antibodies Market Size (2018-2029)
1.6.1 North America HER2 Antibodies Market Size (2018-2029)
1.6.2 Europe HER2 Antibodies Market Size (2018-2029)
1.6.3 Asia-Pacific HER2 Antibodies Market Size (2018-2029)
1.6.4 Latin America HER2 Antibodies Market Size (2018-2029)
1.6.5 Middle East & Africa HER2 Antibodies Market Size (2018-2029)
2 HER2 Antibodies Market by Type
2.1 Introduction
2.1.1 Trastuzumab
2.1.2 Lapatinib
2.1.3 Ado-trastuzumab emtansine
2.1.4 Pertuzumab
2.1.5 Everolimus
2.2 Global HER2 Antibodies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HER2 Antibodies Historic Market Size by Type (2018-2023)
2.2.2 Global HER2 Antibodies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HER2 Antibodies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HER2 Antibodies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HER2 Antibodies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HER2 Antibodies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HER2 Antibodies Revenue Breakdown by Type (2018-2029)
3 HER2 Antibodies Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 E-commerce
3.2 Global HER2 Antibodies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HER2 Antibodies Historic Market Size by Application (2018-2023)
3.2.2 Global HER2 Antibodies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HER2 Antibodies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HER2 Antibodies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HER2 Antibodies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HER2 Antibodies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HER2 Antibodies Revenue Breakdown by Application (2018-2029)
4 HER2 Antibodies Competition Analysis by Players
4.1 Global HER2 Antibodies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HER2 Antibodies as of 2022)
4.3 Date of Key Players Enter into HER2 Antibodies Market
4.4 Global Top Players HER2 Antibodies Headquarters and Area Served
4.5 Key Players HER2 Antibodies Product Solution and Service
4.6 Competitive Status
4.6.1 HER2 Antibodies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis HER2 Antibodies Products, Services and Solutions
5.1.4 Novartis HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer HER2 Antibodies Products, Services and Solutions
5.2.4 Pfizer HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche HER2 Antibodies Products, Services and Solutions
5.3.4 Roche HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.3.5 Abnova Recent Developments
5.4 Abnova
5.4.1 Abnova Profile
5.4.2 Abnova Main Business
5.4.3 Abnova HER2 Antibodies Products, Services and Solutions
5.4.4 Abnova HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.4.5 Abnova Recent Developments
5.5 InvivoGen
5.5.1 InvivoGen Profile
5.5.2 InvivoGen Main Business
5.5.3 InvivoGen HER2 Antibodies Products, Services and Solutions
5.5.4 InvivoGen HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.5.5 InvivoGen Recent Developments
5.6 Celltrion
5.6.1 Celltrion Profile
5.6.2 Celltrion Main Business
5.6.3 Celltrion HER2 Antibodies Products, Services and Solutions
5.6.4 Celltrion HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.6.5 Celltrion Recent Developments
5.7 Biocon
5.7.1 Biocon Profile
5.7.2 Biocon Main Business
5.7.3 Biocon HER2 Antibodies Products, Services and Solutions
5.7.4 Biocon HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.7.5 Biocon Recent Developments
5.8 Novus Biologicals
5.8.1 Novus Biologicals Profile
5.8.2 Novus Biologicals Main Business
5.8.3 Novus Biologicals HER2 Antibodies Products, Services and Solutions
5.8.4 Novus Biologicals HER2 Antibodies Revenue (US$ Million) & (2018-2023)
5.8.5 Novus Biologicals Recent Developments
6 North America
6.1 North America HER2 Antibodies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HER2 Antibodies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibodies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HER2 Antibodies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibodies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HER2 Antibodies Market Dynamics
11.1 HER2 Antibodies Industry Trends
11.2 HER2 Antibodies Market Drivers
11.3 HER2 Antibodies Market Challenges
11.4 HER2 Antibodies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
